Anti-IL23R monoclonal antibody

Anti-IL23R antibody for FACS & in-vivo assay

Target products collectionGo to IL23R/IL23R products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T00484-Ab-1/ GM-Tg-hg-T00484-Ab-2Anti-Human IL23R monoclonal antibodyHuman
GM-Tg-rg-T00484-Ab-1/ GM-Tg-rg-T00484-Ab-2Anti-Rat IL23R monoclonal antibodyRat
GM-Tg-mg-T00484-Ab-1/ GM-Tg-mg-T00484-Ab-2Anti-Mouse IL23R monoclonal antibodyMouse
GM-Tg-cynog-T00484-Ab-1/ GM-Tg-cynog-T00484-Ab-2Anti-Cynomolgus/ Rhesus macaque IL23R monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T00484-Ab-1/ GM-Tg-felg-T00484-Ab-2Anti-Feline IL23R monoclonal antibodyFeline
GM-Tg-cang-T00484-Ab-1/ GM-Tg-cang-T00484-Ab-2Anti-Canine IL23R monoclonal antibodyCanine
GM-Tg-bovg-T00484-Ab-1/ GM-Tg-bovg-T00484-Ab-2Anti-Bovine IL23R monoclonal antibodyBovine
GM-Tg-equg-T00484-Ab-1/ GM-Tg-equg-T00484-Ab-2Anti-Equine IL23R monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T00484-Ab-1/ GM-Tg-hg-T00484-Ab-2; GM-Tg-rg-T00484-Ab-1/ GM-Tg-rg-T00484-Ab-2;
GM-Tg-mg-T00484-Ab-1/ GM-Tg-mg-T00484-Ab-2; GM-Tg-cynog-T00484-Ab-1/ GM-Tg-cynog-T00484-Ab-2;
GM-Tg-felg-T00484-Ab-1/ GM-Tg-felg-T00484-Ab-2; GM-Tg-cang-T00484-Ab-1/ GM-Tg-cang-T00484-Ab-2;
GM-Tg-bovg-T00484-Ab-1/ GM-Tg-bovg-T00484-Ab-2; GM-Tg-equg-T00484-Ab-1/ GM-Tg-equg-T00484-Ab-2
Products NameAnti-IL23R monoclonal antibody
Formatmab
Target NameIL23R
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL23R benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IL23R VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T00484-Ag-1Interleukin 23 receptor (IL23R) protein
    ORF Viral VectorvGMLP004146human IL23R Lentivirus particle
    ORF Viral VectorpGMLP004146human IL23R Lentivirus plasmid


    Target information

    Target IDGM-T00484
    Target NameIL23R
    Gene ID149233,209590,689932,700440,609732,101087763,614367,100053807
    Gene Symbol and SynonymsIL-23R,IL23R,PSORS7
    Uniprot AccessionQ5VWK5
    Uniprot Entry NameIL23R_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000162594
    Target ClassificationN/A

    The target: IL23R, gene name: IL23R, also named as . The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.